Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ENXTPA:OVH
ENXTPA:OVHIT

OVHcloud (ENXTPA:OVH) Profitability Marks Earnings Breakout, Challenging Cautious Valuation Narratives

OVH Groupe (ENXTPA:OVH) has turned profitable, posting 32.7% annual earnings growth over the past five years and now targeting an even stronger 63.8% yearly increase. That outpaces the broader French market’s 12.2% forecast, while revenue is projected to rise at 7.3% per year, also beating the national average. Despite impressive improvements in margins and profit quality, the shares recently traded at €8.49, above some fair value estimates. Investors are weighing robust growth expectations...
CNSX:HBFG
CNSX:HBFGHealthcare Services

The Bull Case For Happy Belly Food Group (CNSX:HBFG) Could Change Following Heal Wellness's Eaton Centre Debut

Happy Belly Food Group recently announced that Heal Wellness has signed a franchise agreement and secured a prime location at Toronto's Eaton Centre, one of Canada’s busiest retail destinations. This move marks Heal Wellness’s first presence in a high-traffic, flagship venue and supports rapid expansion, with over 168 new locations in development and 626 franchise commitments across Happy Belly’s portfolio. We'll explore how entering the Eaton Centre reflects on Happy Belly Food Group's...
NYSE:RS
NYSE:RSMetals and Mining

Should You Reconsider Reliance After Its 3.9% Monthly Dip and Latest Valuation Analysis?

Thinking about what to do with Reliance stock right now? You’re not alone. With so much buzz in the market and news cycles pushing headlines faster than ever, it’s easy to feel both curious and cautious. Reliance has been a favorite among long-term investors, and for good reason. The last five years alone saw the stock rally a remarkable 180.3%. Even over the past three years, despite a few bumps, Reliance delivered a strong 48.1% gain. However, more recently, things have been a bit choppier...
TSXV:WEB
TSXV:WEBRenewable Energy

TSX Penny Stocks To Consider In October 2025

As we approach the end of 2025, the Canadian market is navigating a landscape marked by economic uncertainties such as trade tensions and emerging credit concerns. Despite these challenges, favorable factors like anticipated interest rate cuts and positive corporate earnings growth suggest a resilient outlook for investors. In this context, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for those seeking growth at lower price points. By...
TSE:5105
TSE:5105Auto Components

Toyo Tire (TSE:5105): Valuation Spotlight After CEO Confidence and Share Buyback Plans

Toyo Tire (TSE:5105) shares are getting attention after the CEO projected the company will surpass profit forecasts this year, citing ongoing strong US demand and a planned share buyback program. See our latest analysis for Toyo Tire. After a bumpy start to the year, Toyo Tire’s momentum has shifted into high gear, with the latest leadership confidence and share buyback plans fueling a powerful rally. The one-year total shareholder return now stands at an impressive 107%, and strong demand...
NYSEAM:ARMP
NYSEAM:ARMPBiotechs

A Look at Armata Pharmaceuticals’s Valuation After Positive Phase 2a Bacteriophage Trial Results (ARMP)

Armata Pharmaceuticals (ARMP) just reported encouraging Phase 2a trial results for its experimental IV bacteriophage therapy, AP-SA02, targeting complicated Staphylococcus aureus bacteremia. The data was revealed during a presentation at IDWeek 2025. See our latest analysis for Armata Pharmaceuticals. News of Armata’s clinical breakthrough sent its share price surging 103% in a single day, fueling a remarkable 261% gain for investors year-to-date. Recent momentum has reversed previous years...
NYSE:FPI
NYSE:FPISpecialized REITs

Insider Buying Highlights 3 Undervalued Small Caps Across Regions

Amidst a backdrop of U.S.-China trade tensions and ongoing government shutdown, major stock indexes have ended lower as investors digest recent earnings reports. In this challenging market environment, identifying promising small-cap stocks can be pivotal, especially those that show resilience and potential for growth despite broader economic pressures.
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

High Growth Tech Stocks in the US to Watch for October 2025

As the U.S. market grapples with a mix of earnings reports and renewed U.S.-China trade tensions, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have recently faced downward pressure. In such a volatile environment, identifying high growth tech stocks requires careful consideration of their resilience to geopolitical issues and their ability to innovate amidst economic challenges.
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

3 Promising Penny Stocks With Market Caps Over $700M

Major stock indexes in the United States recently ended lower as investors grappled with earnings reports and renewed U.S.-China trade tensions. Despite these challenges, penny stocks remain an intriguing investment option for those seeking growth opportunities in smaller or newer companies. While the term "penny stocks" might seem outdated, these investments can still offer surprising value when backed by strong financials, providing a potential mix of stability and long-term potential.
ASX:PAR
ASX:PARBiotechs

Paradigm Biopharmaceuticals (ASX:PAR): Assessing Valuation as Investor Focus Builds Ahead of Ignite Summit Presentation

Paradigm Biopharmaceuticals (ASX:PAR) is drawing increased attention ahead of its scheduled presentation at the Ignite Investment Summit in Hong Kong, where the company’s founder and executive team will address investors. See our latest analysis for Paradigm Biopharmaceuticals. After a year defined by volatility, Paradigm's share price has rebounded sharply with a 56% gain over the past month. This signals fresh momentum ahead of its summit appearance. While the short-term rally is grabbing...
SEHK:6110
SEHK:6110Specialty Retail

Topsports (SEHK:6110) Margin Decline Undercuts Bullish Growth Narratives as Premium Valuation Persists

Topsports International Holdings (SEHK:6110) posted a 13.3% annual decline in earnings over the past five years, with net profit margins dipping to 4.6% from last year's 6.3%. Despite this, analysts now forecast the company to deliver 14.2% annual earnings growth going forward, even as revenue is only expected to grow at 4.1% per year, which lags behind the Hong Kong market average of 8.6%. Margin compression remains front of mind for investors as they weigh upbeat earnings forecasts against...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

S&P 500 Futures Rise on Looming Fed Rate Cut Bets

The Morning Bull - US Market Morning Update Thursday, Oct, 23 2025 US equity futures are mixed this morning as investors navigate low Treasury yields and shifting interest rate expectations. With the 10-year yield parked near one-year lows and a widely anticipated Federal Reserve rate cut on the horizon, the focus turns to what easier policy might mean for consumer activity and borrowing. The upcoming inflation report is set to influence sentiment, prompting investors to weigh whether lower...
ASX:SYL
ASX:SYLConstruction

Global Undervalued Small Caps With Insider Action In October 2025

As global markets navigate a volatile landscape marked by easing monetary policies from the U.S. Federal Reserve and fluctuating trade tensions, small-cap stocks have shown resilience, with indices like the Russell 2000 reflecting a notable year-to-date increase. In this environment, identifying promising small-cap opportunities involves looking for companies that demonstrate strong fundamentals and potential for growth amidst broader economic uncertainties.
SZSE:002512
SZSE:002512Electronic

3 Promising Global Penny Stocks With At Least US$500M Market Cap

Global markets have experienced a volatile week, with U.S. stocks rebounding after a sharp sell-off and dovish signals from Federal Reserve officials suggesting potential monetary policy easing. For investors exploring beyond the major indices, penny stocks—typically representing smaller or newer companies—continue to hold relevance as an investment area despite their somewhat outdated label. This article will explore three penny stocks that demonstrate financial strength and offer promising...
NasdaqCM:SPAI
NasdaqCM:SPAIAerospace & Defense

Evaluating Safe Pro Group (SPAI): Valuation Insights Following New AI Detection Milestones and Industry Partnerships

Safe Pro Group (SPAI) recently caught attention as its AI-driven technology demonstrated strong capabilities in detecting landmines and unexploded ordnance. With proven success across commercial, military, and humanitarian missions, the company continues to deepen partnerships with major drone industry players. See our latest analysis for Safe Pro Group. After climbing rapidly earlier this year, Safe Pro Group’s share price has been on a wild ride, down 6.2% in the last day and nearly 20%...
BIT:NWL
BIT:NWLFood

Does the Lowered Princes Group IPO Valuation Reshape NewPrinces' (BIT:NWL) Long-Term Growth Strategy?

Italy's NewPrinces recently announced a lowered valuation target of up to £1.2 billion for the IPO of its Princes Group unit in London, a figure that fell short of initial expectations of £1.5 billion. This revised target attracted increased market scrutiny, highlighting questions about future growth prospects and the evolving appetite for new listings in the sector. With the IPO valuation revision as a focal point, we'll consider how this shift may impact NewPrinces' broader investment...
NasdaqGS:REPL
NasdaqGS:REPLBiotechs

Will FDA Progress Change Replimune Group's (REPL) Position in the Advanced Melanoma Treatment Market?

Replimune Group, Inc. recently announced that the U.S. FDA has accepted its resubmitted Biologics License Application for RP1 in combination with nivolumab, intended for advanced melanoma patients who have progressed on anti-PD-1 therapies, with a new PDUFA target date set for April 10, 2026. This regulatory acceptance represents a major step for Replimune after the company addressed earlier FDA feedback, potentially opening the door to new treatment options for patients with limited...
NYSE:WGO
NYSE:WGOAuto

Winnebago (WGO): Profit Turnaround Forecast Challenges Bearish Narratives on Value and Sustainability

Winnebago Industries (WGO) remains unprofitable, with losses having increased at a rate of 24.1% per year over the past five years. Looking ahead, however, earnings are forecast to climb 45.74% per year and the company is expected to achieve profitability within the next three years, while revenue is projected to grow at 8.1% annually, a pace that is slower than the broader US market. With a Price-to-Sales ratio at just 0.4x, well below peers and the industry average, investors may see...
NYSE:ARW
NYSE:ARWElectronic

Examining Arrow Electronics After This Year’s 9.3% Dip and Shifting Industry Dynamics

Thinking about whether to hold, buy, or move on from Arrow Electronics? You’re not alone. After all, it’s been a somewhat bumpy ride for Arrow shareholders lately. Even though the stock closed at $120.07 recently, it has retreated about 1.5% over the past month and is still down 9.3% for the year. That said, it’s posted gains of 7.8% year-to-date, and if you zoom out to the past three or five years, you’ll find solid returns of 20.8% and 56.9%, respectively. That is enough of a track record...